52 week high-3.27. Hard to come up with enough su

52 week high-3.27. Hard to come up with enough superlatives for MMPJoe and the management team. However, the job is not done until we uplist to NASDAQ. The 1:1 dividend catalyst is still in play and will bolster the pps until 7/23. We have to expect a dip after 7/23 unless there is significant news. The best news would be progress in uplisting. Additional real earnings, or "paychecks" as MMPJoe called them, would also be nice. Until GNBT is uplisted it is still a small biotech listed on the OTC market. If and when GNBT is uplisted, it won't be beholden to PR's to maintain its pps. It can be judged on its own like any other NASDAQ company, although more positive PR's are always welcome. A good start to the weekend for longs.